Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve

Clinical trial NCT07117682 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07117682
Sponsor: Cytori Therapeutics
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diminished Ovarian Reserve (DOR)Primary Ovarian Insufficiency (Poi)Ovarian Failure, Premature

Start date: 2025-08-25
Primary completion: 2027-02-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.